Fig. 2From: FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational studyKaplan-Meier curve of progression-free survival. The median progression-free survival was 1.3 months (95% confidence interval, 1.0–1.5)Back to article page